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There is mounting evidence that childhood leukaemia is associated with high birth weight, but few studies have examined the
relationship between leukaemia and other perinatal factors that influence birth weight, such as maternal weight or gestational weight
gain. This case-cohort study included 916 acute lymphocytic leukaemia (ALL) and 154 acute myeloid leukaemia (AML) cases
diagnosed prior to age 10 years between 1985 and 2001 and born in New York State excluding New York City between 1978 and
2001. Controls (n¼9686) were selected from the birth cohorts for the same years. Moderate increased risk of both ALL and AML
was associated with birth weight 3500g or more. For ALL, however, there was evidence of effect modification with birth weight and
maternal prepregnancy weight. High birth weight was associated with ALL only when the mother was not overweight while heavier
maternal weight was associated with ALL only when the infant was not high birth weight. Increased pregnancy-related weight gain
was associated with ALL. For AML, birth weight under 3000g and higher prepregnancy weight were both associated with increased
risk. These findings suggest childhood leukaemia may be related to factors influencing abnormal fetal growth patterns.
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Leukaemia is the most common form of childhood cancer. There is
strong evidence that at least some childhood leukaemias that arise
before the age of 14 years have prenatal origins (Greaves et al,
2003), but despite a growing understanding of the molecular
carcinogenic process, the risk factors for the pre- and postnatal
DNA mutations associated with leukaemia are not known. There is
mounting evidence that higher birth weight is associated with
childhood leukaemia. A recent meta-analysis of birth weight and
leukaemia found approximately 25% increased risk of both acute
lymphocytic leukaemia (ALL) and acute myeloid leukaemia (AML)
with birth weight over 4000g, although the studies of AML showed
more heterogeneity than the studies of ALL (Hjalgrim et al, 2003).
Other birth-related factors for which the association with ALL is
suggestive include older maternal age and history of fetal loss prior
to index birth (Little, 1999). Maternal subfertility has been
suggested as a potential factor in the aetiology of ALL (Steensel-
Moll et al, 1985). Being the first-born or only child and higher
socioeconomic status has also been associated with increased risk
of ALL, which Kinlen (1988) and Greaves et al (2003) hypothesised
is due to differential risk of age-specific exposure to viruses. For
AML, there have been several studies suggesting associations with
maternal alcohol consumption during pregnancy and parental
exposure to pesticides or benzene (Little, 1999).
We used existing public health surveillance data to perform a
case-cohort study of leukaemia and perinatal risk factors. We
hypothesised that high birth weight, first born status, older
maternal age and history of prior fetal loss would be associated
with the risk of both ALL and AML. The data collected on the New
York State birth certificate also allowed for exploratory analysis
with respect to factors associated with birth weight and fetal
growth. In addition to birth weight and gestational age, several risk
factors for macrosomia are available from the New York State birth
records, including maternal diabetes, multiparity, prior history of
a macrosomic infant, postdate gestation, maternal weight, and
pregnancy weight gain.
MATERIALS AND METHODS
Leukaemia cases were ascertained from the New York State Cancer
Registry. All cases age 1 month to 9 years diagnosed with acute
leukaemia between 1985 and 2001 while resident of New York State
and born in New York State excluding New York City were eligible
to be included in the study. Children with leukaemia diagnosed
subsequent to another form of cancer were excluded. Eligibility
was determined by matching the leukaemia cases to the electronic
birth files of children born in New York State between 1978
through 2001. Because the birth certificate used in New York State
differs from the certificate used in New York City and other states,
children who were found to have been born in New York City or
out-of-state were excluded, as were children who were not matched
to electronic birth certificate records. Leukaemias were grouped
into ALL and AML based on the ICD-O-3 version of the
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yFoucher et al, 2005). We excluded 79 matched leukaemia cases
who could not be classified as either ALL or AML, including 35
children with unspecified types of leukaemia and 44 children
with chronic or other specified leukaemia. Immunophenotype
was not available for 85% of ALL cases, and was therefore not
included in the analysis. One case was diagnosed simultaneously
with both ALL and AML, and is included in the analyses for both
outcomes.
Controls were selected from electronic birth files of all children
whose place of birth was New York State excluding New York City
between 1978 and 2001. This study was a subset of a larger study,
which included childhood cancer cases for all cancer sites. Two
controls were selected for each cancer case included in the larger
study, resulting in 9686 controls. As the data elements available
from the birth records vary by year of birth, controls were
frequency matched to the cases included in the larger study based
on year of birth to assure consistency of availability of
information. For the purposes of individual cancer types such as
reported here, frequency of birth year was not necessarily
proportional between cases and controls. One ALL case was also
selected as a control, and was retained in the analysis as both a
case and a control. Additionally, 13 controls were also in the
registry-birth match and therefore were known to have developed
other forms of cancer or benign brain tumours. Children who died
in the neonatal period (within 28 days of birth) were also excluded,
because cases diagnosed at less than 1 month of age were excluded
from the case series.
The independent variables for this study came from the birth
certificates of the cases and controls. The birth certificates are
completed by the staff at the hospital where the child is born. Data
from the birth certificates are routinely abstracted and entered
onto the electronic master live birth file, and are available for the
birth cohorts included in this study (1978–2001). The birth
certificates underwent major revisions in 1988 and 1993. In
addition to changes in the birth certificate itself, the data items
available on the master birth file have also changed, as has the
coding of individual variables. Owing to these changes, some
independent variables were not available for analysis for all
cases. For example, maternal height was not collected on the
New York State birth certificates until 1993, and therefore
maternal body mass index could not be calculated for 75% of
leukaemia cases and 81% of controls. Maternal prepregnancy
weight was collected starting in 1988, and was missing for a similar
proportion of cases and controls born between 1998 and 2001 (7.6
and 8.0%, respectively). Maternal weight and weight gain were
recorded in pounds on the birth certificate and converted to
kilograms for this analysis. There was evidence of end-digit
preference in reporting weight gain in pounds, with modes at 20,
25, 30 and 40 pounds. We used these modes for cutpoints in the
analysis, which resulted in unusual weight gain categories when
reported in kilograms.
This study design was a case-cohort study; therefore, the odds
ratio provides an estimate of the cumulative incidence (risk)
ratio (Rothman and Greenland, 1998). We defined high birth
weight as 3500g or more, very high birth weight as 4500g or more,
and low birth weight as less than 2500g. We used 80kg to indicate
heavier maternal weight, which corresponds to obesity for an
average height woman (body mass index of 30 for a woman of
163cm), but would be considered normal weight for a tall woman
(body mass index 23.7 for a woman 180cm). Separate analyses
were conducted for ALL and AML. For ALL, additional analyses
were conducted stratified by age at diagnosis. Unconditional
logistic regression was used for multivariate analysis. As some
exposures changed prevalence over the course of the study period,
birth year, as a continuous variable, was included in all regression
models. Unless otherwise noted, all models included birth year,
birth weight, gender, gestational age, maternal age, race and
ethnicity.
RESULTS
Acute lymphocytic leukaemia
There were 1102 ALL cases diagnosed in New York State excluding
New York City who were eligible to be included in the study. Birth
certificate matches were made for 916 cases, resulting in a match
proportion of 83%. The estimated match proportion was slightly
higher for cases diagnosed ages 0–4 years (87%) compared to
cases diagnosed 5–9 years of age (76%).
The birth weight distribution of ALL cases and controls is
presented in Table 1, with stratification by age at diagnosis. High
birth weight was associated with increased risk of ALL. The
adjusted odds ratio for birth weight of 3500g or more, compared
to birth weight under 3500g, was 1.17 (95% confidence interval
1.01, 1.35). In addition, lower birth weights were associated with
decreased risk. The odds ratio for birth weight under 3000g was
0.76 (95% confidence interval 0.61, 0.94), relative to 3000–3499g.
The test for trend for increasing ALL risk with increasing birth
weight was statistically significant (P¼0.0015), and the adjusted
odds ratio associated with a 1000g increase in birth weight as a
continuous variable was 1.25 (95% confidence interval 1.08, 1.43).
This association did not vary by age. The adjusted odds ratio for
high birth weight for ALL diagnosed within the first 4 years of life
was 1.18 (95% confidence interval 0.99, 1.40), while the adjusted
odds ratio for diagnosis at ages 5 to 9 years was 1.15 (95%
confidence interval 0.90, 1.48). The test for trend, however, was not
statistically significant for ALL diagnosed at ages 5–9 years.
Maternal prepregnancy weight was not statistically significantly
associated with increased risk of ALL (Table 1), although there was
evidence of a dose response, with a significant test for trend for
ALL at all ages (P¼0.03) and for diagnosis prior to the age of 5
years (P¼0.002). Body mass index classified as overweight or
obese (425) was associated with an adjusted odds ratio of 1.44
(95% confidence interval 1.03, 2.01) for ALL diagnosis prior to the
age of five, relative to body mass index of 20–24. Since maternal
height was not collected prior to 1993, maternal body mass index
was not available for the ALL diagnosed at an older age. There was
evidence of interaction between maternal prepregnancy weight and
ALL as well (Table 2). High birth weight and heavier maternal
weight were themselves associated; among controls, the adjusted
odds ratio for the risk of high birth weight associated with
maternal weight over 80kg was 1.85 (95% confidence interval 1.54,
2.23). We observed increased risk of ALL among children whose
births weights were discordant with the mother’s weight. That is,
increased risk was observed among children who were heavier at
birth but whose mothers were not heavy, as well as among children
without high birth weight but whose mothers were heavier.
Conversely, increased risk was not observed among children
whose birth weights were concordant with maternal weight,
indicating antagonistic effect modification. The interaction term
in the logistic regression model for high birth weight and heavier
maternal weight as dichotomised in Table 2 was statistically
significant (P¼0.006). These results varied slightly by age at
diagnosis, although the number of cases became sparse (Table 2).
For ALL diagnosed between the ages of 5 and 9 years, the
combination of high birth weight and high maternal weight was
protective, but only two cases in the age group with this combined
exposure were observed.
Higher maternal weight gain during pregnancy was also
associated with ALL (Table 1), and there was no evidence of
interaction with birth weight or maternal weight in the logistic
regression model (P¼0.14). The pattern of increased risk with
more weight gain was consistent across the two age groups
examined, although the odds ratios did not reach statistical
significance for leukaemia diagnosed at ages 5–9 years. When
dichotomised into weight gain of more than 14kg, relative to
o14kg, the adjusted odds ratio for ALL was 1.31 (95% confidence
Leukaemia and birth weight
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yTable 1 Adjusted odd ratios for other maternal and infant birth characteristics, acute lymphocytic leukaemia (ALL) and acute monocytic leukaemia (AML)
children born in New York State excluding New York City, 1978–2000
Controls ALL (all ages) ALL age 0–4 years ALL age 5–9 years AML (all ages)
N (%) N (%) RR
a (95% CI) N (%) RR
a (95% CI) N (%) RR
a (95% CI) N (%) RR
a (95% CI)
Birth weight
o2500g 587 (6.1) 42 (4.6) 0.73 (0.50, 1.06) 21 (3.3) 0.46 (0.27, 0.75) 21 (7.3) 1.47 (0.84, 2.48) 12 (7.9) 1.94 (0.88, 4.00)
2500–2999g 1466 (15.2) 107 (11.7) 0.77 (0.61, 0.97) 81 (12.9) 0.85 (0.64, 1.11) 26 (9.1) 0.59 (0.37, 0.91) 26 (17.1) 1.77 (1.04, 2.96)
3000–3499g 3496 (36.2) 332 (36.2) 1 (reference) 227 (36.0) 1 (reference) 105 (36.7) 1 (reference) 37 (24.3) 1 (reference)
3500–3999g 2999 (31.0) 313 (34.2) 1.07 (0.91, 1.26) 210 (33.3) 1.06 (0.86, 1.29) 103 (36.0) 1.11 (0.84, 1.47) 51 (33.6) 1.59 (1.03, 2.49)
4000–4499g 935 (9.7) 101 (11.0) 1.10 (0.86, 1.39) 77 (12.2) 1.22 (0.92, 1.60) 24 (8.4) 0.85 (0.53, 1.32) 18 (11.8) 1.90 (1.04, 3.36)
4500+g 184 (1.9) 21 (2.3) 1.10 (0.67, 1.73) 14 (2.2) 1.05 (0.57, 1.78) 7 (2.4) 1.26 (0.52, 2.57) 8 (5.3) 3.89 (1.63, 8.26)
Gender
Male 5069 (52.4) 520 (56.8) 1.18 (1.02, 1.36) 366 (58.1) 1.23 (1.04, 1.46) 154 (53.8) 1.07 (0.84, 1.37) 84 (54.9) 1.14 (0.82, 1.60)
Female 4603 (47.6) 396 (43.2) 1 (reference) 264 (41.9) 1 (reference) 132 (46.2) 1 (reference) 69 (45.1) 1 (reference)
Race and ethnicity
White non-Hispanic 7326 (75.9) 746 (81.8) 1 (reference) 508 (80.9) 1 (reference) 238 (83.8) 1 (reference) 118 (76.6) 1 (reference)
Black 641 (6.6) 33 (3.6) 0.51 (0.35, 0.72) 23 (3.7) 0.51 (0.32, 0.77) 10 (3.5) 0.51 (0.25, 0.92) 13 (8.4) 0.94 (0.47, 1.71)
Hispanic 1284 (13.3) 92 (10.1) 0.78 (0.61, 0.98) 68 (10.8) 0.89 (0.67, 1.16) 24 (8.5) 0.58 (0.37, 0.89) 19 (12.3) 0.97 (0.56, 1.57)
Other 403 (4.2) 41 (4.5) 0.90 (0.63, 1.26) 29 (4.6) 0.87 (0.57, 1.29) 12 (4.2) 0.98 (0.50, 1.74) 4 (2.6) 0.46 (0.14, 1.13)
Gestational age
o35 weeks 304 (3.2) 27 (3.0) 1.23 (0.77, 1.89) 21 (3.4) 1.72 (1.01, 2.80) 6 (2.1) 0.59 (0.22, 1.34) 5 (3.3) 0.85 (0.28, 2.15)
35–37 weeks 830 (8.8) 82 (9.0) 1.18 (0.90, 1.51) 56 (8.9) 1.22 (0.89, 1.63) 26 (9.2) 1.09 (0.68, 1.68) 16 (10.6) 1.06 (0.57, 1.85)
38–41 weeks 6505 (68.9) 628 (68.9) 1 (reference) 432 (68.8) 1 (reference) 196 (69.0) 1 (reference) 101 (66.9) 1 (reference)
42+ weeks 1801 (19.1) 156 (17.1) 0.95 (0.78, 1.14) 104 (16.6) 0.95 (0.75, 1.82) 52 (18.3) 0.94 (0.68, 1.28) 29 (19.2) 1.01 (0.64, 1.55)
Pregnancy weight gain (1988–2001 births only)
o8.6kg 511 (13.2) 60 (12.8) 1.31 (0.90, 1.91) 43 (12.5) 1.21 (0.78, 1.87) 17 (13.9) 1.59 (0.78, 3.28) 19 (19.4) 1.45 (0.73, 2.90)
9.1–11.3kg 696 (18.0) 65 (13.9) 1 (reference) 49 (14.2) 1 (reference) 16 (13.1) 1 (reference) 18 (18.4) 1 (reference)
11.8–13.6kg 749 (19.4) 83 (17.8) 1.12 (0.79, 1.59) 64 (18.6) 1.12 (0.75, 1.67) 19 (15.6) 1.11 (0.56, 2.21) 17 (17.3) 0.90 (0.44, 1.84)
14.1–18.1kg 1138 (29.5) 158 (33.8) 1.42 (1.04, 1.94) 113 (32.8) 1.30 (0.92, 1.87) 45 (36.9) 1.80 (1.02, 3.34) 25 (25.5) 0.88 (0.47, 1.71)
18.6+ kg 766 (19.8) 101 (21.6) 1.38 (0.99, 1.94) 76 (22.0) 1.35 (0.92, 2.00) 25 (20.5) 1.45 (0.76, 2.82) 19 (19.4) 0.83 (0.41, 1.68)
Prepregnancy weight (1988–2001 births only)
o56kg 1102 (28.0) 119 (25.2) 1 (reference) 80 (22.8) 1 (reference) 39 (32.2) 1 (reference) 20 (20.0) 1 (reference)
56–67kg 1539 (39.1) 183 (38.8) 1.05 (0.82, 1.35) 136 (38.7) 1.15 (0.86, 1.55) 47 (38.8) 0.86 (0.55, 1.34) 42 (42.0) 1.54 (0.89, 2.75)
68–79kg 775 (19.7) 99 (21.0) 1.18 (0.88, 1.58) 74 (21.1) 1.30 (0.92, 1.83) 25 (20.7) 0.95 (0.56, 1.60) 15 (15.0) 0.89 (0.42, 1.83)
80+ kg 522 (13.3) 71 (15.0) 1.25 (0.89, 1.73) 61 (17.4) 1.54 (1.06, 2.23) 10 (8.3) 0.58 (0.26, 1.17) 23 (23.0) 2.25 (1.18, 4.34)
Maternal diabetes
Present 164 (1.8) 25 (2.9) 1.44 (0.91, 2.18) 18 (3.0) 1.37 (0.80, 2.21) 7 (2.6) 2.29 (0.86, 5.10) 1 (0.7) 0.26 (0.02, 1.18)
Not recorded 9085 (98.2) 846 (97.1) 1 (reference) 579 (97.0) 1 (reference) 267 (97.4) 1 (reference) 145 (99.3) 1 (reference)
Maternal age
o20 years 885 (9.1) 66 (7.2) 0.93 (0.69, 1.22) 43 (6.9) 0.94 (0.66, 1.31) 23 (8.1) 0.91 (0.55, 1.43) 16 (10.4) 1.62 (0.89, 2.78)
20–29 years 5615 (58.0) 482 (52.6) 1 (reference) 311 (49.9) 1 (reference) 171 (60.4) 1 (reference) 72 (46.8) 1 (reference)
30–34 years 2306 (23.8) 268 (29.3) 1.21 (1.03, 1.42) 199 (31.9) 1.34 (1.11, 1.62) 69 (24.4) 0.96 (0.72, 1.27) 41 (26.6) 1.16 (0.77, 1.73)
35–39 years 763 (7.9) 90 (9.8) 1.23 (0.96, 1.56) 70 (11.2) 1.41 (1.06, 1.86) 20 (7.1) 0.87 (0.52, 1.36) 18 (11.7) 1.45 (0.83, 2.42)
40+ years 115 (1.2) 10 (1.1) 0.86 (0.40, 1.63) 7 (1.1) 0.99 (0.41, 2.00) 3 (1.1) 0.62 (0.10, 2.00) 7 (4.5) 3.68 (1.48, 7.85)
aRelative risk and 95% confidence interval adjusted for birth year, gender, race and ethnicity, maternal age, gestational age and birth weight.
Table 2 Adjusted odd ratios for high birth weight and heavier maternal weight, acute lymphocytic leukaemia children born in New York State excluding
New York City, 1988–2000
Controls Cases (all ages) Cases (ages 0–4 years) Cases (ages 5–9 years)
Birth weight (g) Maternal weight (kg) N (%) N (%) RR
a (95% CI) N (%) RR
a (95% CI) N (%) RR
a (95% CI)
o3500 o80 2012 (51.1) 209 (44.3) 1.00 (reference) 157 (44.7) 1.00 (reference) 52 (43.0) 1.00 (reference)
o3500 80+ 228 (5.8) 40 (8.5) 1.72 (1.16, 2.48) 32 (9.1) 1.72 (1.11, 2.60) 8 (6.6) 1.67 (0.72, 3.40)
3500+ o80 1404 (35.7) 192 (40.7) 1.26 (1.01, 1.57) 133 (37.9) 1.14 (0.88, 1.46) 59 (48.8) 1.65 (1.11, 2.46)
3501+ 80+ 294 (7.5) 31 (6.6) 0.99 (0.64, 1.48) 29 (8.3) 1.21 (0.77, 1.83) 2 (1.7) 0.16 (0.01, 0.75)
aRelative risk and 95% confidence interval adjusted for birth year, gender, race and ethnicity, maternal age and gestational age.
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yinterval 1.07, 1.60). For ALL diagnosed prior to the fifth birthday,
the adjusted odds ratio was 1.26 (95% confidence interval 1.00,
1.59) and for ages 5–9 it was 1.46 (95% confidence interval 1.01,
2.14).
Maternal diabetes was associated with nonsignificant increased
risk of ALL after controlling for the other weight factors. For ALL
diagnosed prior to the age of 5 years, older maternal age was
associated with increased risk, but no increased risk was observed
for older age at diagnosis. Other factors examined, but which were
not associated with risk of ALL in the multivariate analysis include
paternal age, first born status, number of previous live births,
maternal history of prior fetal loss, publicly funded financial
assistance during pregnancy, method of delivery or use of obstetric
procedures during pregnancy and delivery, infertility treatment,
maternal smoking or drug use, other maternal medical risk factors
such as hypertension, or infant medical risk factors such as birth
injury or assisted ventilation (data not shown).
Acute myeloid leukaemia
There were 186 AML cases eligible to be in the study, of whom 154
matched to birth records, resulting in an estimated match
proportion of 83%. The cell types of AML included in this study
included AML, not otherwise specified (96 cases), acute promye-
locytic leukaemia (12 cases), acute myelomonocytic leukaemia (15
cases), acute monocytic leukaemia (16 cases), acute megakaryo-
blastic leukaemia (11 cases) and four cases with other AML cell
types.
Both low birth weight and high birth weight were associated
with increased risk of AML, as was heavier prepregnancy weight
(Table 1). Owing to the small number of AML cases, we also
analysed birth weight with wider categories. The odds ratio for
birth weight under 3000g, relative to 3000–3499g, was 1.80 (95%
confidence interval 1.11, 2.59); for birth weight over 3500g the
odds ratio was 1.76 (1.18, 2.68). Unlike ALL, however, there was no
evidence of interaction between birth weight and maternal weight
in the logistic regression model (P¼0.41). Additionally, higher
weight gain during pregnancy was not associated with AML. In
fact, there was a trend towards decreasing risk with increasing
weight gain, and the test for trend was borderline statistically
significant (one-sided P for trend¼0.046). Older maternal age was
also associated with increased risk of AML. The adjusted odds
ratio for maternal age 40 years or older, relative to 20–29 years of
age, was 3.68 (95% confidence interval 1.48, 7.85). As with ALL, we
did not observe associations between AML and the other maternal
or infant risk factors examined (data not shown).
DISCUSSION
A recent meta-analysis of 18 studies from the 1940s onward found
higher risk of ALL with birth weight of over 4000g (pooled odds
ratio of 1.26, 95% confidence interval 1.17–1.37) (Hjalgrim et al,
2003). In addition, risk increased 14% with each 1000g increase in
birth weight. While some studies have been negative (Robison
et al, 1987; Kaye et al, 1991; Savitz and Ananth, 1994; Dockerty
et al, 1999; Thompson et al, 2001; Ma et al, 2005), the majority of
studies support a weak to moderate increased risk of ALL
among children who had heavier birth weights (Buckley et al,
1994; Cnattingius et al, 1995; Ross et al, 1997; Westergaard et al,
1997; Yeazel et al, 1997; Smulevich et al, 1999; Suminoe et al, 1999;
Murray et al, 2002; Okcu et al, 2002; Reynolds et al, 2002; Shu
et al, 2002), including some studies published since the meta-
analysis (Hjalgrim et al, 2004; Jourdan-Da Silva et al, 2004; Lee
et al, 2004; Paltiel et al, 2004). Our findings with respect to birth
weight are consistent with previous studies. The presence of
possible interaction with maternal weight, however, suggests that
the relationship between birth weight and ALL may be more
complex than previously described. In our results, birth weight was
associated with increased risk of ALL only when the mother’s
weight was not heavy. Conversely, children born to heavier
mothers but whose birth weights were not high were also at
increased risk. Children with high birth weight concordant with
high maternal weight were not at increased risk of ALL. This
antagonistic effect modification supports the previously suggested
hypothesis that factors related to prenatal growth, rather than birth
weight per se, are involved in the mechanism by which birth weight
is associated with ALL. These findings warrant further study, since
our evaluation of this interaction was exploratory in nature, and
limited to births occurring between 1988 and 2001.
In Hjalgrim’s meta-analysis, the point estimate of the risk ratio
for birth weight and AML was of similar magnitude as for ALL,
although not statistically significant (pooled odds ratio 1.27, 95%
confidence interval 0.73–2.20) and 29% increase in risk per 1000g
increase in birth weight. For AML, however, there was evidence of
heterogeneity, with two studies showing a nonsignificant protec-
tive effect of high birth weight (Shu et al, 1999; Reynolds et al,
2002) and two studies showing a statistically significant elevated
relative risk (Westergaard et al, 1997; Suminoe et al, 1999). In our
study, we did not observe a dose response for birth weight and
AML. Rather, AML was associated with both low birth weight and
high birth weight. The U-shaped dose–response curve for birth
weight and AML was also reported in a recent large study from
Scandinavia (Hjalgrim et al, 2004). Most studies that have reported
on AML and birth weight in ordinal categories have not yielded
similar results (Shu et al, 1988; Ross et al, 1997; Yeazel et al, 1997;
Shu et al, 1999; Reynolds et al, 2002; Jourdan-Da Silva et al, 2004),
although several used relatively high cutoffs (2700 or 3000g) for
the lowest birth weight category (Shu et al, 1988; Ross et al, 1997;
Yeazel et al, 1997; Shu et al, 1999). The presence of a nonlinear
effect would explain the heterogeneity among studies in the meta-
analysis.
A number of mechanisms have been suggested to explain the
observed association between birth weight and leukaemia, includ-
ing insulin-like growth factor I (IGF-I), which is associated with
higher birth weight and hypothesised to stimulate myeloid and
lymphoid cells (Ross et al, 1996), and decreased thyroid function
in the prenatal period, which is inversely correlated with birth
weight and is hypothesised to be associated with leukaemia by
leading to decreased cell turn over or by a direct affect on
lymphocytes (Lei et al, 2000).
Birth weight is a complicated outcome, which is itself associated
not only with gestational age and infant health but also with a
number of maternal risk factors, including weight and weight for
height, pregnancy weight gain, multiparity, diabetes, race and
ethnicity, diet, smoking and other drug use, and the mother’s own
birth weight (Skjaerven et al, 1997; Orskou et al, 2003; Ehrenberg
et al, 2004; Clausen et al, 2005). These factors are all potentially
related to leukaemia through uncontrolled confounding, indepen-
dent affects, effect modification, or by acting along the same causal
pathway. We were able to explore a number of these factors in this
study, and, in addition to prepregnancy weight, we observed
increased risk of ALL with pregnancy weight gain, but no
association with multiparity, diabetes, smoking or history of
previous high birth weight infants. Obesity and excessive weight
gain can cause hyperglycemia in both the mother and infant.
Exposure to hyperglycemia would increase the infant’s production
of insulin, and the possibility of exposure to hyperglycemia during
pregnancy and increased risk of childhood and adult chronic
diseases associated with impaired glucose metabolism is under
study (Boney et al, 2005). Concerning the antagonistic effect
modification between birth weight and maternal weight observed
in this study, several studies have observed effect modification
between with maternal weight and markers of insulin metabolism
in relation to macrosomia (Jaksic et al, 2001; Ehrenberg et al, 2004;
Clausen et al, 2005). For example, Clausen et al (2005)
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levels of insulin resistance compared to heavier mothers with large
babies. Ehrenberg et al (2004) reported that the influence of
diabetes on birth weight was stronger for normal and underweight
women, compared to overweight women. Chronic (preconception)
diabetes and maternal obesity may also introduce additional
maternal medical risk factors such as cardiovascular problems and
nephropathy (Boulet et al, 2003). Maternal obesity could also be
associated with increased endogenous hormones and toxin
buildup in adipose tissue.
We also observed increased risk of both ALL and AML with
older maternal age, although the results were stronger for AML
and for ALL diagnosed under age 5 years. The hypothesis that
older maternal age may be associated with childhood leukaemia
arises from the joint fact that older maternal age is associated with
increased risk of chromosomal malformations, and the fact that
childhood leukaemia is a disease related to chromosomal breakage
and translocation. A few earlier studies published in the 1960s or
early 1970s suggested a weak increased risk of leukaemia or
leukaemia death among offspring born to older mothers in the
United States (Manning and Carroll, 1957; MacMahon and Newill,
1962; Stark and Mantel, 1969; Fasal et al, 1971). Since then,
however, most studies of maternal age and the risk of leukaemia in
the offspring have been negative or have shown weak, nonsigni-
ficant elevated risk with older maternal age (Salonen and Saxen,
1975; Kneale and Stewart, 1976; Shaw et al, 1984; Steensel-Moll
et al, 1985; McKinney et al, 1987, 1999; Shu et al, 1988, 1994, 1999;
Zack et al, 1991; Cnattingius et al, 1995; Petridou et al, 1997;
Roman et al, 1997; Ross et al, 1997; Westergaard et al,
1997; Dockerty et al, 1999; Thompson et al, 2001; Murray et al,
2002; Okcu et al, 2002; Jourdan-Da Silva et al, 2004). A handful of
studies have resulted in statistically significant increased risk
ratios in the order of 1.5–2.0 for ALL or all leukaemias among
children born to women older than age 35 years at delivery (Kaye
et al, 1991; Buckley et al, 1994; Hemminki et al, 1999; Mogren et al,
1999; Dockerty et al, 2001; Reynolds et al, 2002; Shu et al, 2002;
Jourdan-Da Silva et al, 2004). Little (1999) proposed that the lack
of consistency between the early studies and those conducted later
was due to the introduction of easily accessible contraception and
abortion, which has introduced the possibility of confounding by
socioeconomic status. Among the positive studies, there is no
distinct pattern of elevated risk related to maternal age in terms of
the child’s age at diagnosis, leukaemia subtype or gender.
As a case-cohort study, lack of follow-up of controls creates a
potential for selection bias. The potential loss-to-follow-up in this
study arises from the fact that controls were ascertained from
existing records with no subsequent follow-up (other than
eliminating potential controls who died within the first month of
life). By sampling the controls from the birth cohorts, we are
assuming that the controls had they developed cancer, would have
been ascertained as cases in the study, and that no controls leave
the risk set due to death. Controls who develop cancer may be
missed if they migrate out of New York or, less likely, if they were
unreported to the state cancer registry. Childhood mortality is
associated, either directly or indirectly, with several of the
perinatal factors being studied, including infant birth weight and
maternal age. After the immediate postnatal period, childhood
mortality is low (National Center for Health Statistics, 1994).
Despite these limitations, the use of a case-cohort study design
based on cancer registry and birth records has several advantages
over a case–control study design based on interviews with respect
to selection bias. By using administrative record data instead of
interview, there is less potential for self-selection bias related to
refusal of cases or controls to participate in the study or selection
bias related to inability to trace and contact study subjects.
Use of birth certificate data for ascertaining perinatal exposures
reduces the potential for differential misclassification; since all
measurement is made prior to diagnosis and measurement does
not rely on parental recall of pregnancy history. Birth certificates,
however, may be problematic for epidemiologic studies due to
problems with completeness and validity (Kirby, 2001). In a study
of the validity of electronic birth certificate data for New York State
excluding New York City, Roohan observed that the sensitivity of
maternal medical risk factors on the birth certificates varied, but
specificity was high (Acar et al, 2001; Roohan et al, 2003). For
maternal prepregnancy weight and weight at delivery, the birth
certificates were within five pounds of the weight (2.2kg) recorded
in the medical record for over 87% of records sampled (Acar et al,
2001). Lack of sensitivity of the birth certificate may also explain
why several potential risk factors that have been suggested in
previous studies were not confirmed in this study.
By using the birth certificate data, we were able to examine a
number of factors related to infant’s birth weight, some of which
have not been reported on in previous studies. Our findings related
to maternal weight and pregnancy weight gain are therefore
exploratory, but, given the high prevalence of overweight and
obesity, the possible association with childhood leukaemia should
be examined in other cohorts. Maternal weight and height, as well
as pregnancy weight gain, were added to the United States
standard birth certificate in 2003. While the use of the birth
certificate for epidemiologic studies has been questioned, the
future availability of these data may promote cost-effective,
population-based studies of perinatal risk factors for childhood
cancer.
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